Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 367
Filtrar
2.
Z Gastroenterol ; 54(1): 19-25, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26751113

RESUMEN

The various efficient methods available for bowel preparation prior to colonoscopy differ in patient acceptance. Combining the laxative sodium picosulfate with hyperosmotic magnesium citrate, used in this study in the formulation CitraFleet(®), allows the uptake of the purgative substances as a solution of low volume. This observational study with 737 patients evaluated efficacy of bowel preparation, potential side or adverse effects and patient acceptance of this medicinal product when used by resident physicians in Germany.Colon cleansing with CitraFleet(®) was considered very good to sufficient in 95.2 % of the patients and inadequate in only 4.8 %. In 75 % of the colonoscopies, bowel preparation was rated very good or good. Compared to the standard regimen of two portions taken the day before endoscopy, cleaning efficacy was better when patients received one of the doses on the morning of the day of colonoscopy. The quality of bowel preparation was rated lower by gastroenterologists without any prior experience with sodium picosulfate/magnesium citrate. The overall assessment of the colon cleansing procedure by the 76 participating physicians was very positive and patient acceptance was also very high which can be considered a clear advantage over alternative methods. Efficacy of colon cleansing with CitraFleet(®) was not substantially affected by typical deviations from the recommended standard procedure, emphasizing the robustness of the method. Only one of the patients reported a mild adverse effect potentially caused by the cleansing agents.


Asunto(s)
Actitud del Personal de Salud , Citratos/administración & dosificación , Ácido Cítrico/administración & dosificación , Colonoscopía/estadística & datos numéricos , Enfermedades Gastrointestinales/epidemiología , Compuestos Organometálicos/administración & dosificación , Aceptación de la Atención de Salud/estadística & datos numéricos , Picolinas/administración & dosificación , Adulto , Anciano , Catárticos/administración & dosificación , Catárticos/efectos adversos , Citratos/efectos adversos , Ácido Cítrico/efectos adversos , Combinación de Medicamentos , Femenino , Enfermedades Gastrointestinales/inducido químicamente , Alemania/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Compuestos Organometálicos/efectos adversos , Picolinas/efectos adversos , Premedicación/estadística & datos numéricos , Prevalencia , Resultado del Tratamiento
3.
Z Gastroenterol ; 53(12): 1447-95, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26666283

RESUMEN

Chronic pancreatitis is a disease of the pancreas in which recurrent inflammatory episodes result in replacement of pancreatic parenchyma by fibrous connective tissue. This fibrotic reorganization of the pancreas leads to a progressive exocrine and endocrine pancreatic insufficiency. In addition, characteristic complications arise, such as pseudocysts, pancreatic duct obstructions, duodenal obstruction, vascular complications, obstruction of the bile ducts, malnutrition and pain syndrome. Pain presents as the main symptom of patients with chronic pancreatitis. Chronic pancreatitis is a risk factor for pancreatic carcinoma. Chronic pancreatitis significantly reduces the quality of life and the life expectancy of affected patients. These guidelines were researched and compiled by 74 representatives from 11 learned societies and their intention is to serve evidence-based professional training as well as continuing education. On this basis they shall improve the medical care of affected patients in both the inpatient and outpatient sector. Chronic pancreatitis requires an adequate diagnostic workup and systematic management, given its severity, frequency, chronicity, and negative impact on the quality of life and life expectancy.


Asunto(s)
Endoscopía Gastrointestinal/normas , Pancreatectomía/normas , Pruebas de Función Pancreática/normas , Pancreatitis/diagnóstico , Pancreatitis/terapia , Guías de Práctica Clínica como Asunto , Enfermedad Crónica , Alemania , Humanos , Estados Unidos
4.
Rofo ; 186(11): 1002-8, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25122174

RESUMEN

UNLABELLED: Chronic pancreatitis shows an increasing prevalence and incidence mainly in the Western Hemisphere. Early diagnosis and therapy are frequently delayed because of non-specific symptoms as well as non-specific blood values. The German Society of Digestive and Metabolic Diseases (DGVS) organized the preparation and publication of an interdisciplinary S3 level guideline with the support of the German Radiological Society (DRG) as 1 of 11 contributing societies. In this article we present and discuss the main topics of the guideline regarding the diagnosis, differential diagnosis and therapy of complications of this complex chronic disease with a focus on clinical and scientific radiologists. KEY POINTS: • Ultarsound represents the perfect first line imaging modality • For further diagnostic werk up MRI with MRCP are recommended for the differential diagnosis of pancreatic cancer • For clinical studies the modified (CT, MRI) Cambridge classification is recommended.


Asunto(s)
Conducta Cooperativa , Diagnóstico por Imagen , Comunicación Interdisciplinaria , Pancreatitis Crónica/diagnóstico , Pancreatitis Crónica/terapia , Medios de Contraste , Diagnóstico Tardío , Estudios de Seguimiento , Humanos , Aumento de la Imagen , Imagen por Resonancia Magnética , Páncreas/patología , Seudoquiste Pancreático/clasificación , Seudoquiste Pancreático/diagnóstico , Seudoquiste Pancreático/terapia , Pancreatitis Crónica/clasificación , Pancreatitis Crónica/complicaciones , Pronóstico , Sensibilidad y Especificidad , Ultrasonografía
7.
Dtsch Med Wochenschr ; 139(3): 79-83, 2014 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-24089288

RESUMEN

BACKGROUND: If the diagnosis is made early the cure rate of bowel cancer is more than 90 %. Occupational preventative medical care required by law and carried out by company physicians can be supplemented by a medical consultation and by simple screenings to interest employees in cancer prevention and refer them to registered general practitioners and specialist doctors for further diagnosis and treatment. SUBJECTS AND METHODS: Since 2001, BASF SE in Ludwigshafen, Germany offers its employees aged 45 and more a program to detect intestinal cancer early. The employees receive personal invitations for this program once a year. The participants answer a standard questionnaire about risk factors for bowel cancer and an endoscopic diagnosis, if this has already been carried out, and receive a FOBT. Since 2010 an immunological test system was used. We compare the results from two consecutive years with a Guajacum test system (g-FOBT) and an immunological test (i-FOBT). The German Association of Digestive and Metabolic Diseases, DGVS, recommends a colonoscopy if test results are positive or a family member has suffered from bowel cancer. RESULTS: Between 2008 and 2011, a total of 52,797 invitations were sent to employees aged 45 and over. Overall, 16,730 men (37.7 % of 46,245) and 1,585 women (24.4 % of 6,552) took part (in some cases more than once). The return rate of the FOBT increased from 66.7 % in 2008 to 79.5 % in 2011. Due to positive results and/or suspicious information in the questionnaire, 2,441 colonoscopies were recommended, 849 of them because of a positive FOBT. The medical department was informed of 224 endoscopy diagnoses. In 8 cases, manifested cancer (6 × colon, 2 × rectum) and in 57 cases adenomatous polyps were diagnosed as preliminary stages of cancer. Most of these diagnoses were made using the i-FOBT, the simultaneous increase in positive test results and therefore more frequent recommendations for a colonoscopy. CONCLUSION: The additional offer of a program for early detection of bowel cancer as part of an occupational surveillance examination helps detecting bowel cancer early in employees who show no symptoms. Since men on average fall ill earlier, it makes sense to offer these tests at the age of 45.  Personal invitations lead to consistently high participant rates and the simplicity of the i-FOBT leads to high return rates of tests. The rate of positive test results is higher compared to g-FOBT. In our follow-up, significantly more intestinal cancer and possible preliminary stages were detected through screening with the immunological test.


Asunto(s)
Neoplasias Colorrectales/diagnóstico , Detección Precoz del Cáncer/métodos , Guayaco , Sangre Oculta , Servicios de Salud del Trabajador , Pólipos Adenomatosos/diagnóstico , Pólipos Adenomatosos/patología , Pólipos Adenomatosos/prevención & control , Colonoscopía , Neoplasias Colorrectales/patología , Neoplasias Colorrectales/prevención & control , Diagnóstico Precoz , Femenino , Estudios de Seguimiento , Alemania , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Valor Predictivo de las Pruebas
10.
Radiologe ; 53(9): 775-82, 2013 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-23933636

RESUMEN

Colorectal cancer (CRC) is responsible for 27,000 deaths and 65,000 new cancers in Germany each year, although this should be unnecessary as CRC is preventable because it is possible to remove the precursors, harmless polyps and adenomas. However, only 2.5 % of people in health insurance make use of screening colonoscopy annually so that it becomes necessary to check out other screening tests. The most commonly used test is the Guaiak-based test for fecal occult blood (gFOBT) which is highly specific but not very sensitive (only approximately 10 %). New immunological stool tests are more sensitive but the specificity is reduced from 90 % to approximately 80 %. Virtual colonoscopy based on computed tomography (CT) or magnetic resonance imaging (MRI) is comparable to endoscopy for diagnostics with overall accuracy rates of approximately 80-90 % for polyps larger than 5 mm but for radiation protection reasons CT is not usable in Germany and MRI is internationally not adequately established by large study trials. For the future there is much hope in molecular blood tests. It is of great importance that every physician is aware of the different tests, their strengths and weaknesses and advises all patients to use the different screening possibilities.


Asunto(s)
Colonografía Tomográfica Computarizada/estadística & datos numéricos , Neoplasias Colorrectales/diagnóstico por imagen , Neoplasias Colorrectales/epidemiología , Errores Diagnósticos/prevención & control , Errores Diagnósticos/estadística & datos numéricos , Detección Precoz del Cáncer/estadística & datos numéricos , Procedimientos Innecesarios , Neoplasias Colorrectales/prevención & control , Medicina Basada en la Evidencia , Alemania/epidemiología , Humanos , Prevención Primaria/estadística & datos numéricos , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
18.
Endoscopy ; 44(5): 482-6, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22275051

RESUMEN

BACKGROUND AND STUDY AIMS: Colon capsule endoscopy (CCE) offers an alternative approach for endoscopic visualization of the colon. Some of the current CCE bowel cleansing regimens use sodium phosphate, which has raised safety concerns. Therefore, the aim of the current study was to test the feasibility and efficacy of a new low-volume, sodium phosphate-free polyethylene glycol (PEG) bowel preparation. METHODS: The first 26 patients (original cleansing procedure) received a colon cleansing regimen of PEG plus ascorbic acid: patients drank 1 L in the evening and 0.75 L in the morning before capsule ingestion. Patients also drank an additional 0.5 L PEG boost and an optional 0.25 L PEG boost during the capsule procedure. Following an interim analysis, the cleansing procedure of the subsequent 24 patients was modified, with the morning intake before capsule ingestion being increased to 1 L, as well as the second boost (0.25 L) being administered 1 - 2 hours earlier (modified cleansing procedure). RESULTS: The overall colon cleanliness was considered to be good or excellent in 83 % (original cleansing procedure) and 82 % (modified cleansing procedure) of patients, without any significant difference between regimens (P > 0.05). In 37 /49 (76 %) of the CCE procedures, the hemorrhoidal plexus was identified and thus the examination was considered complete, with no significant differences between the two CCE cleansing procedures. The capsule sensitivity and specificity for detecting colonic polyps ≥ 6 mm were 91 % (95 %CI 70 % - 98 %) and 94 % (95 %CI 87 % - 97 %), respectively, compared with standard optical colonoscopy. CONCLUSION: A colon cleansing procedure using PEG + ascorbic acid for capsule colonoscopy yielded an adequate cleansing level in > 80 % of patients, a completion rate of 76 %, and good accuracy for detecting polyps. This procedure may be considered as an alternative, particularly for patients in whom sodium phosphate-based preparations are contraindicated.


Asunto(s)
Endoscopía Capsular , Catárticos/administración & dosificación , Pólipos del Colon/diagnóstico , Enema/métodos , Polietilenglicoles/administración & dosificación , Adulto , Anciano , Ácido Ascórbico/administración & dosificación , Colonoscopía , Femenino , Tránsito Gastrointestinal , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Sensibilidad y Especificidad
19.
Dig Dis ; 29 Suppl 1: 53-5, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22104754

RESUMEN

Europe has made significant progress in recent years by introducing population-based screening programs for colorectal cancer. Due to excellent evidence-based results on the basis of large prospective randomized trials, mass screening using the fecal occult blood test is currently the procedure of choice. Endoscopy-based programs do afford quality insurance programs which are outlined in the recommendations of the European Commission.


Asunto(s)
Colonoscopía/métodos , Colonoscopía/tendencias , Neoplasias Colorrectales/diagnóstico , Detección Precoz del Cáncer/métodos , Detección Precoz del Cáncer/tendencias , Europa (Continente) , Geografía , Humanos , Seguro
20.
Z Gastroenterol ; 49(10): 1428-31, 2011 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-21964898

RESUMEN

The National Cancer Programme of the German Federal Administration aims to assess the present status of the national fight against cancer in Germany. Experts in their field have analysed the present target-performance comparison in different working groups dealing with topics from cancer prevention to follow-up and have developed recommendations as to how improvements in the various fields of cancer care may be achieved and mainly how these imrpovements may be implemented in day-to-day cancer care. The working group "Advancement of Colon Cancer Screening, Early Detection and Prevention" proposes the establishment of regulatory proposals for a nationwide, population-based, postal invitational process and, according to Pilot-Projects in Bavaria and Baden-Wuerttemberg, to evaluate the essential recommendations in data protection, logistics, documentation and financing. There are already several programmes in preparation--for example, the Saarland Offensive, based on the results of the KolosSal-Study.


Asunto(s)
Neoplasias Colorrectales/diagnóstico , Detección Precoz del Cáncer/métodos , Política de Salud , Programas Nacionales de Salud , Anciano , Causas de Muerte , Colonoscopía , Neoplasias Colorrectales/mortalidad , Neoplasias Colorrectales/patología , Diagnóstico Precoz , Femenino , Alemania , Implementación de Plan de Salud , Prioridades en Salud , Humanos , Masculino , Persona de Mediana Edad , Sangre Oculta , Aceptación de la Atención de Salud , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA